Geode Capital Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.51M | Buy |
|
|||||
|
2025
Q1 | $6.4M | Buy |
|
|||||
|
2024
Q4 | $9.55M | Buy |
|
|||||
|
2024
Q3 | $7.15M | Buy |
|
|||||
|
2024
Q2 | $9.24M | Buy |
|
|||||
|
2024
Q1 | $4.7M | Buy |
|
|||||
|
2023
Q4 | $3.33M | Buy |
|
|||||
|
2023
Q3 | $951K | Buy |
|
|||||
|
2023
Q2 | $1.14M | Sell |
|
|||||
|
2023
Q1 | $2.1M | Buy |
|
|||||
|
2022
Q4 | $7.97M | Buy |
|
|||||
|
2022
Q3 | $7.55M | Buy |
|
|||||
|
2022
Q2 | $6.97M | Sell |
|
|||||
|
2022
Q1 | $5.16M | Buy |
|
|||||
|
2021
Q4 | $4.14M | Buy |
|
|||||
|
2021
Q3 | $4.12M | Sell |
|
|||||
|
2021
Q2 | $9.54M | Buy |
|
|||||
|
2021
Q1 | $12.6M | Buy |
|
|||||
|
2020
Q4 | $10.6M | Buy |
|
|||||
|
2020
Q3 | $14.8M | Buy |
|
|||||
|
2020
Q2 | $19.9M | Buy |
|
|||||
|
2020
Q1 | $11.7M | Buy |
|
|||||
|
2019
Q4 | $20.6M | Sell |
|
|||||
|
2019
Q3 | $12.9M | Buy |
|
|||||
|
2019
Q2 | $16.2M | Buy |
|
|||||
|
2019
Q1 | $11.8M | Buy |
|
|||||
|
2018
Q4 | $12.7M | Buy |
|
|||||
|
2018
Q3 | $11.3M | Buy |
|
|||||
|
2018
Q2 | $8.41M | Buy |
|
|||||
|
2018
Q1 | $12.9M | Buy |
|
|||||
|
2017
Q4 | $11.5M | Sell |
|
|||||
|
2017
Q3 | $8.85M | Buy |
|
|||||
|
2017
Q2 | $6.57M | Buy |
|
|||||
|
2017
Q1 | $4.82M | Buy |
|
|||||
|
2016
Q4 | $1.62M | Buy |
|
|||||
|
2016
Q3 | $1.54M | Buy |
|
|||||
|
2016
Q2 | $1.08M | Buy |
|
|||||
|
2016
Q1 | $1.81K | Buy |
|
|||||
|
2015
Q4 | $2.03M | Buy |
|
|||||
|
2015
Q3 | $2.08M | Sell |
|
|||||
|
2015
Q2 | $7.79M | Buy |
|
|||||
|
2015
Q1 | $8.12M | Buy |
|
|||||
|
2014
Q4 | $2.18M | Buy |
|
|||||
|
2014
Q3 | $733K | Buy |
|
|||||
|
2014
Q2 | $474K | Sell |
|
|||||
|
2014
Q1 | $459K | Sell |
|
|||||
|
2013
Q4 | $418K | Buy |
|
|||||
|
2013
Q3 | $572K | Buy |
|